Where does Recursion Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Recursion Pharmaceuticals, Inc. ranks #10,440 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Recursion Pharmaceuticals, Inc. hold?

Recursion Pharmaceuticals, Inc. holds 30 US utility patents granted between 2018 and 2025, spanning 22 technology areas.

What is Recursion Pharmaceuticals, Inc.'s Innovation Score?

Recursion Pharmaceuticals, Inc. has an Innovation Score of 55.5 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Recursion Pharmaceuticals, Inc. focus on?

Recursion Pharmaceuticals, Inc.'s top technology area is G06F (Electric Digital Data Processing) with 13 patents. Grants appear in 22 CPC subclasses total.

Is Recursion Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Recursion Pharmaceuticals, Inc.'s recent grant velocity is +1050% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Recursion Pharmaceuticals, Inc.'s patents?

Recursion Pharmaceuticals, Inc.'s patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Recursion Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Recursion Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 30 granted patents across 22 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06F (Electric Digital Data Processing).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Recursion ranks #10,440 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 22 technology areas.

#10,440
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.5/100): 18.1
avg claims per patent: +1050%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10440 · US Corporation #10,440 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,440/49,997
PHOTO-FINISH Radie B V
CPC-FOCUS G06F · 22 areas
INNOV-PAR 55.5/100
CLAIMS-RICH 18.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1050% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Radie B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
University of… · near

56
Joulwatt Technology · near

56
Recursion Pharmaceut… · this assignee

56
SK microworks · near

56
Equashield Medical · near

55
3D Lighting… · lowest

7

What this shows Recursion's Innovation Score is 55.5/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Recursion's grants concentrate

Recursion Pharmaceuticals, Inc. is a focused PatentsView assignee: 22 CPC subclasses with 43.3% of grants classified under G06F (Electric Digital Data Processing). Peak complete grant year is 2024 (9 grants) versus a trough of 1 in 2018. By volume, Recursion sits between RCM Enterprise L.L.C. and Scaleflux, Inc..

Recursion's three-year grant acceleration

Recursion Pharmaceuticals, Inc. shows 17 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

RCM Enterprise L…

30
Recensmedical

30
Rtic Outdoors

30
Radie B V

30
Armstrong

30
Photonics

30
Salvatore Ferraga…

30
Scaleflux

30
Recursion Pharmac… ◀

30

What this shows Recursion holds 30 patents at rank #10,441, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Recursion

By rank, the assignees closest to #10,441 in granted patent volume.

Leaders in G06F (Electric Digital Data Processing)

Other assignees with the most granted patents in Recursion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Recursion, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (56 here).

SK microworks Co., Ltd. 56 Joulwatt Technology Co., Ltd. 56 Equashield Medical Ltd 55 University of Strathclyde 56

Recursion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Recursion Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	3.3%
2019	1	3.3%
2020	1	3.3%
2021	5	16.7%
2022	4	13.3%
2023	4	13.3%
2024	9	30.0%
2025partial year	5	16.7%

Which technologies does Recursion Pharmaceuticals, Inc. patent most?

G06F - Electric Digital Data Processing 13

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 12

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 9

G06T - Image Data Processing OR Generation, IN General 9

G06V - Image OR Video Recognition OR Understanding 6

G06N - Computing Arrangements Based ON Specific Computational Models 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

Y02A - Technologies FOR Adaptation TO Climate Change 3

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 2

A61B - DIAGNOSIS; SURGERY; Identification 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 1

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

H04N - Pictorial Communication, e.g. Television 1

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#10,440

of 49,997 tracked assignees

Innovation Score

55.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Recursion Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Recursion Pharmaceuticals, Inc.'s lead technology class is G06F (Electric Digital Data Processing), 43.3% of its portfolio - see every assignee active in that class. Explore G06F
Ranked #10,440 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Recursion Pharmaceuticals, Inc. against RCM Enterprise L.L.C., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.